Approaches to implement bispecific antibody treatment of ovarian carcinoma

Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):187-9. doi: 10.1007/s002620050429.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bispecific / administration & dosage
  • Antibodies, Bispecific / immunology
  • Antibodies, Bispecific / therapeutic use*
  • CD28 Antigens / immunology
  • CD3 Complex / immunology*
  • Carrier Proteins / immunology*
  • Female
  • Folate Receptors, GPI-Anchored
  • Humans
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Lymphocyte Activation / immunology
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / therapy*
  • Receptors, Cell Surface*
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Bispecific
  • CD28 Antigens
  • CD3 Complex
  • Carrier Proteins
  • Folate Receptors, GPI-Anchored
  • Receptors, Cell Surface